ИностранцамНовостиКонтакты
БОЛЬНИЦЫ УНИВЕРСИТЕТАХАДЖЕТТЕПЕ
Запись
RU
  1. Главная
  2. Врачи
  3. Проф. д-р Ümit Yavuz Malkan
Проф. д-р Ümit Yavuz Malkan

Проф. д-р

Ümit Yavuz Malkan

Гематология · Больница для взрослых

Злокачественные гематологические заболеваниятрансплантация гемопоэтических стволовых клетоклейкозлимфомамножественная миеломанарушения свёртываемости и кровотечения и другие болезни крови.
Записаться на приём

О враче

Проф. д-р Ümit Yavuz Malkan: место и год рождения — Анкара, 1985 г. Начальное, среднее и старшее образование — в Анкарском колледже TED. Окончание медицинского факультета Университета Хаджеттепе — 2008 г. Специализация по медицине завершена в 2013 г., квалификация специалиста по внутренним болезням. В 2014 г. начало узкой специализации на научном отделении гематологии кафедры внутренних болезней медицинского факультета Университета Хаджеттепе. В 2014 г. Турецким обществом гематологии присуждена премия «Молодой исследователь». В 2015 г. получена премия «TÜRKBA» Турецкого общества гематологии. По результатам научных исследований в 2015 г. присуждена поощрительная премия Общества гематологической онкологии. В 2017 г. успешно завершена узкая специализация на научном отделении гематологии кафедры внутренних болезней медицинского факультета Университета Хаджеттепе, квалификация специалиста-гематолога. В 2018 г. пройдена программа «Мастер-класс по множественной миеломе», организованная Турецким обществом гематологии. В 2018 г. присвоено звание доцента по гематологии. В 2020 г. обучение по гематологическим злокачественным заболеваниям и клеточной терапии в отделении гематологических злокачественных заболеваний и клеточных методов лечения Университета Дьюка (штат Северная Каролина, США). В 2021 г. назначение на должность преподавателя-доцента на научное отделение гематологии кафедры внутренних болезней медицинского факультета Университета Хаджеттепе. В 2023 г. получен сертификат о квалификации и опыте в области «Аутологичной и аллогенной трансплантации стволовых клеток». В 2025 г. присвоено звание профессора по внутренним болезням/гематологии медицинского факультета Университета Хаджеттепе. Проф. д-р Ümit Yavuz Malkan — редактор раздела гематологии в «Международном журнале гематологии и онкологии». Опубликовано множество научных статей в национальных и международных рецензируемых журналах. На работы, включённые в национальные и международные индексы, имеются сотни цитирований. Член Турецкого общества гематологии и Европейской гематологической ассоциации, член правления Общества трансплантации крови и костного мозга и Общества гематологической онкологии. В настоящее время — преподаватель, профессор на научном отделении гематологии кафедры внутренних болезней медицинского факультета Университета Хаджеттепе.

Образование

  1. 2017
    Гематология
    Университет Хаджеттепе
  2. 2013
    Внутренние болезни
    Университет Уфук
  3. 2008
    Медицинский факультет
    Университет Хаджеттепе
  4. 2002
    Колледж TED Анкара

Области специализации

Злокачественные гематологические заболеваниятрансплантация гемопоэтических стволовых клетоклейкозлимфомамножественная миеломанарушения свёртываемости и кровотечения и другие болезни крови.

Публикации

Источник: Система управления академическими данными Университета Хаджеттепе (AVESİS) · Все публикации (214) ↗

Articles 117

  1. Clinical Characteristics and Survival Outcomes in Patients with Essential ThrombocythemiaErdoğdu B., BAHTİYAR R. C., ÇINAR O. E., MALKAN Ü. Y., HAZNEDAROĞLU İ. C.Indian Journal of Hematology and Blood Transfusion, cilt.42, sa.4, ss.1244-1254, 2026 (SCI-Expanded, Scopus)
  2. Direct Second Autologous Stem Cell Transplantation Versus Re-Induction Followed by Transplantation in Relapsed Multiple Myeloma: A Multicenter Real-World StudyKars T. U., GÖKER H., DEMİROĞLU H., MALKAN Ü. Y., ALADAĞ KARAKULAK E., Erdekli F. T., et al.Journal of Clinical Medicine, cilt.15, sa.13, 2026 (SCI-Expanded, Scopus)
  3. Assessment of characteristics and treatment patterns of adult patients with acquired aplastic anemia in Turkiye (PLANE-TR)GÜNDÜZ E., Ulas T., ÖZKALEMKAŞ F., TOPRAK S. K., Karakulak E. A., AR M. C., et al.Annals of Hematology, cilt.105, sa.4, 2026 (SCI-Expanded, Scopus)
  4. Time-Dependent Differential Effects of SARS CoV 2 Spike Protein in Lung and Colon Epithelial Cell LinesYILMAZ A., Yaka U., TÜRK S., MALKAN Ü. Y., GÖÇER S., HAZNEDAROĞLU İ. C., et al.Jundishapur Journal of Microbiology, cilt.19, sa.1, 2026 (SCI-Expanded, Scopus)
  5. Metabolomic Profiling of Leukemic Hematopoiesis: Effects of BNT162b2 mRNA COVID-19 Vaccine AdministrationErdogdu B., KAPLAN O., Fidan B. B., ÇELEBİER M., MALKAN Ü. Y., HAZNEDAROĞLU İ. C.CURRENT MOLECULAR MEDICINE, cilt.26, sa.6, ss.616-626, 2026 (SCI-Expanded, Scopus)
  6. Chronic Myeloid Leukemia Transforming into Acute Lymphoblastic Leukemia in a Patient with Gaucher Disease: A Case Report and Literature ReviewSayinalp Arslan B., ÇATAN ERDEKLİ F. T., Sağlam Ayhan A., ALADAĞ KARAKULAK E., MALKAN Ü. Y., BÜYÜKAŞIK Y.Case Reports in Oncology, cilt.19, sa.1, ss.437-443, 2026 (ESCI, Scopus)
  7. Hepatic Metabolic Dysregulation as a Potential Amplifier of Leukemogenesis Following mRNA Vaccination: A Novel Mechanistic HypothesisErdogdu B., KAPLAN O., ÇELEBİER M., MALKAN Ü. Y., HAZNEDAROĞLU İ. C.MEDICINA-LITHUANIA, cilt.61, sa.9, 2025 (SCI-Expanded, Scopus)
  8. Anemia in the patients with acute myeloid leukemia revisited: Prognostic importance of anemia on treatment-naïve patientsÇınar O. E., Malkan U. Y., Aladag E., Demiroglu H., Büyükaşık Y., Göker H., et al.Acta Medica, cilt.56, sa.2, ss.116-121, 2025 (TRDizin)
  9. Effects of Metabolic Parameters on The Clinical Course of Hematological MalignanciesBirsoy B., MALKAN Ü. Y.UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, cilt.35, sa.1, ss.1-11, 2025 (SCI-Expanded, Scopus, TRDizin)
  10. Periorbital edema and phototoxic rash associated with dasatinib: A case reportUĞURLU B. Ö., MALKAN Ü. Y.SAGE OPEN MEDICAL CASE REPORTS, cilt.13, 2025 (ESCI, Scopus)
  11. Differential proinflammatory responses of colon epithelial cells to SARS-CoV-2 spike protein and Pseudomonas aeruginosa lipopolysaccharideYILMAZ A., Turk S., MALKAN Ü. Y., HAZNEDAROĞLU İ. C., Ucar G., ÖZGÜVEN Ş. V., et al.TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, cilt.49, ss.774-783, 2024 (SCI-Expanded, Scopus, TRDizin)
  12. Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experienceYiğit Kaya S., MUTLU Y. G., MALKAN Ü. Y., MEHTAP Ö., Keklik Karadağ F., Korkmaz G., et al.Leukemia Research, cilt.140, 2024 (SCI-Expanded, Scopus)
  13. Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled studyFIRAT O., KARA E., MALKAN Ü. Y., Demirkan K., İNKAYA A. Ç.Thrombosis Research, cilt.236, ss.155-160, 2024 (SCI-Expanded, Scopus)
  14. Pathogens in Pediatric Septic Arthritis: A Multi-Center Study in Turkiye (PEDSART Study)Iseri Nepesov M., KILIÇ Ö., Sali E., Yesil E., Akar A., Kaman A., et al.Children, cilt.11, sa.1, 2024 (SCI-Expanded, Scopus)
  15. Prognostic gene biomarkers for c-Src inhibitor Si162 sensitivity in melanoma cellsTÜRK S., YILMAZ A., MALKAN Ü. Y., UÇAR G., TÜRK C.TURKISH JOURNAL OF BIOLOGY, cilt.48, sa.1, 2024 (SCI-Expanded, Scopus, TRDizin)
  16. The Potential Role of CAL2 and EZH2 Immunohistochemical Stainings as Diagnostic and Prognostic Surrogate Markers in Classical BCR/ABL1-negative Myeloproliferative NeoplasmsÖZOĞUL E., Ozgeyik M. O., AYHAN E. A., MALKAN Ü. Y., HAZNEDAROĞLU İ. C., ÜNER A.UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, cilt.33, sa.4, ss.248-257, 2023 (SCI-Expanded, Scopus, TRDizin)
  17. The Relationship of Vitamin D Levels with Hematological NeoplasiaTopcu F. B., Ozdemir S., MALKAN Ü. Y.UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, cilt.33, sa.4, ss.227-239, 2023 (SCI-Expanded, Scopus, TRDizin)
  18. Clinical Outcomes of CNS Lymphoma Treated with Ibrutinib-Based Therapy: A Real-Life Multicenter Experience on Off-Label Use of IbrutinibILTAR U., SALİM O., Atas U., Vural E., Alhan F. N., YÜCEL O. K., et al.UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, cilt.33, sa.4, ss.191-197, 2023 (SCI-Expanded, Scopus, TRDizin)
  19. Does Systemic Immune Inflammation Index Predicts Survival In Diffuse Large B Cell Lymphoma Patients?REİS ARAS M., Afacan Öztürk H. B., yılmaz f., Güneş A. K., Malkan U. Y., ALBAYRAK M.Hitit medical journal (Online), cilt.5, sa.3, ss.170-174, 2023 (TRDizin)
  20. Immunogenomic approach to the clinical management of COVID-19 syndromeTÜRK S., HAZNEDAROĞLU İ. C., TÜRK C., malkan Ü. Y.Eskisehir Medical Journal, cilt.4, ss.266-279, 2023 (Hakemli Dergi)
  21. Pharmacobiology of topical Ankaferd hemostat in neoplastic disordersMalkan U. Y., Haznedaroglu I. C.The European Research Journal, cilt.9, sa.5, ss.1271-1276, 2023 (TRDizin)
  22. Enterotoxins A and B produced by Staphylococcus aureus increase cell proliferation, invasion and cytarabine resistance in acute myeloid leukemia cell lines.TÜRK S., Yanpar H., Baesmat A. S., Canli S., ÇINAR O. E., MALKAN Ü. Y., et al.Heliyon, cilt.9, sa.9, 2023 (SCI-Expanded, Scopus)
  23. Exploring the distribution and prognostic effect of the ABO blood types of COVID-19 patients during delta and omicron waves: A case control studyGÖKER H., ÇINAR O. E., ISMAYILOV R., Özdemir E., MALKAN Ü. Y., ALADAĞ E., et al.Acta Medica, cilt.54, sa.2, ss.97-102, 2023 (Hakemli Dergi)
  24. Chronic myeloid leukemia, tyrosine kinase inhibitors and cardiovascular system.Malkan Ü. Y., Haznedaroglu I. C.European review for medical and pharmacological sciences, cilt.27, sa.12, ss.5493-5506, 2023 (SCI-Expanded, Scopus)
  25. Hypophosphatemia related to the use of ibrutinibKARADENİZ M., ÇINAR O. E., Erdogdu B., MALKAN Ü. Y., GÖKER H., ÖZCEBE O. İ.Journal of Oncology Pharmacy Practice, 2023 (SCI-Expanded, Scopus)
  26. The Impact of JAK2 Mutation on Thrombosis in Philadelphia Chromosome-Negative Chronic Myeloproliferative NeoplasmsArslan Kapuci A., Tiglioglu P., Hanci L. T., Saat H., MALKAN Ü. Y.UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, cilt.33, sa.2, ss.83-91, 2023 (SCI-Expanded, Scopus, TRDizin)
  27. The Relationship Between GLIM Criteria and Recovery Times in the Leukemia Treatment ProcessYilmaz F., Aras M. R., Afacan Ozturk H. B., MALKAN Ü. Y., Kapuci A. A., Gunes A. K., et al.UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, cilt.33, sa.3, ss.121-126, 2023 (SCI-Expanded, Scopus, TRDizin)
  28. Pathobiological alterations affecting the distinct clinical courses of pediatric versus adult COVID-19 syndromeŞENEL E., TÜRK S., MALKAN Ü. Y., Peker M. Ç., TÜRK C., GÜNER H. R., et al.Turkish Journal of Medical Sciences, cilt.53, sa.5, ss.1194-1204, 2023 (SCI-Expanded, Scopus, TRDizin)
  29. A single-center experience of haploidentical stem cell transplantation in hematological malignanciesMALKAN Ü. Y., GÖKER H., DEMİROĞLU H., Tekin F., Akdemir B., ALADAĞ KARAKULAK E., et al.Turkish Journal of Medical Sciences, cilt.53, sa.1, ss.352-359, 2023 (SCI-Expanded, Scopus, TRDizin)
  30. The Prognostic Significance of Prognostic Nutritional Index in Diffuse Large B Cell Lymphoma PatientsAras M. R., Yilmaz F., Tiglioglu M., Saglam B., Yuzgenc B., Afacan Ozturk H. B., et al.UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, cilt.33, sa.1, ss.8-13, 2023 (SCI-Expanded, Scopus, TRDizin)
  31. The probiotic-induced dysregulation of immune-related genes in colon cells and relation with colorectal cancerTürk S., Yılmaz A., Safari Baesmat A., Malkan Ü. Y., Ucar G., Türk C.Cellular and Molecular Biology, cilt.69, sa.4, ss.37-45, 2023 (SCI-Expanded, Scopus)
  32. Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia After Hematopoietic Stem Cell Transplantation: A Cohort Study in a Tertiary Center Real-World Setting.Göker H., Çınar O. E., Demiroğlu H., Malkan Ü. Y., Aladağ Karakulak E., Büyükaşık Y.Turkish journal of haematology : official journal of Turkish Society of Haematology, cilt.40, ss.213-215, 2023 (SCI-Expanded, Scopus, TRDizin)
  33. Harbinger of Trouble; Fingerprints in the Pre-Senile Stage of NK Cell’s DysfunctionTÜRK S., Baesmat A. S., YILMAZ A., MALKAN Ü. Y., TÜRK C., HAZNEDAROĞLU İ. C., et al.UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, cilt.33, sa.2, ss.66-74, 2023 (SCI-Expanded, Scopus, TRDizin)
  34. Comment on Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874ÇINAR O. E., Erdogdu B., KARADENİZ M., ÜNAL S., MALKAN Ü. Y., GÖKER H., et al.MEDICINA-LITHUANIA, cilt.58, sa.11, 2022 (SCI-Expanded, Scopus)
  35. NK-cell dysfunction of acute myeloid leukemia in relation to the renin-angiotensin system and neurotransmitter genesTÜRK S., Baesmat A. S., YILMAZ A., TÜRK C., MALKAN Ü. Y., UÇAR G., et al.OPEN MEDICINE, cilt.17, sa.1, ss.1495-1506, 2022 (SCI-Expanded, Scopus)
  36. Prophylactic Central Nervous System Irradiation Is Not Indispensable in Adult Patients with Acute Lymphoblastic Leukemia: A Multicenter Retrospective Cohort StudyÇınar O. E., Göker H., Fidan K., Aydın Ö., Pashayev T., Malkan Ü. Y., et al.Turkish journal of haematology : official journal of Turkish Society of Haematology, cilt.39, sa.3, ss.152-159, 2022 (SCI-Expanded, Scopus, TRDizin)
  37. Determination of etiology in patients admitted due to isolated leukopenia.Mart G., Malkan Ü. Y., Buyukasik Y.Medicine, cilt.101, sa.33, 2022 (SCI-Expanded, Scopus)
  38. Antineoplastic Effects of Ankaferd Hemostat.Malkan Ü. Y., Haznedaroglu I. C.BioMed research international, cilt.2022, ss.2665903, 2022 (SCI-Expanded, Scopus)
  39. Analysis of factors associated with the development of myelofibrosis in polycythemia vera and essential thrombocythemia patients: a single-center experienceTiglioglu P., Albayrak M., Yildiz A., Tiglioglu M., Saglam B., Aras M. R., et al.JOURNAL OF HEMATOPATHOLOGY, cilt.15, ss.83-93, 2022 (SCI-Expanded, Scopus)
  40. Association of Human Leukocyte Antigen Genotypes with Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine-Induced Subacute ThyroiditisŞENDUR S. N., ÖZMEN F., Oguz S. H., GÖNÜL İREMLİ B., MALKAN Ü. Y., Gurlek A., et al.THYROID, cilt.32, sa.6, ss.640-647, 2022 (SCI-Expanded, Scopus)
  41. A rare case of DIC in a patient with Wilson's disease: D-penicillaminePARLAR Y. E., BALABAN H. Y., MALKAN Ü. Y., DENİZ E., UYSAL F. R.HEPATOLOGY FORUM, cilt.3, sa.2, ss.61-63, 2022 (ESCI, Scopus, TRDizin)
  42. Efficacy of eltrombopag in thrombocytopenia after hematopoietic stem celltransplantationKARATAŞ A., GÖKER H., DEMİROĞLU H., MALKAN Ü. Y., Velet M., ÇINAR O. E., et al.TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.52, sa.2, ss.413-419, 2022 (SCI-Expanded, Scopus, TRDizin)
  43. Hematological aspects of the COVID-19 syndromeMALKAN Ü. Y., Haznedaroglu I. C.EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, cilt.26, sa.12, ss.4463-4476, 2022 (SCI-Expanded, Scopus)
  44. Covid-19 Related Fatality and Risk Factors in Multiple Myeloma: A Multicenter Cohort StudyKARADENİZ M., GÖKER H., Aydin O., Turgut M., MALKAN Ü. Y., Sener E., et al.UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, cilt.32, sa.4, ss.209-213, 2022 (SCI-Expanded, Scopus, TRDizin)
  45. Improving Survival Besides the High Early Mortality Rate in Acute Promyelocytic LeukemiaMalkan Ü. Y., Koca E., BÜYÜKAŞIK Y.UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, cilt.32, sa.1, ss.1-7, 2022 (SCI-Expanded, Scopus, TRDizin)
  46. The Effect of CRAB Findings on the Prognosis of Multiple Myeloma PatientsKalkisim A. F., Kalkisim H. K., MALKAN Ü. Y.UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi, cilt.32, sa.4, ss.191-201, 2022 (SCI-Expanded, Scopus, TRDizin)
  47. Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 VaccineErdogdu B., ÇINAR O. E., Malkan Ü. Y., AKSU S., DEMİROĞLU H., BÜYÜKAŞIK Y., et al.UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, cilt.32, sa.1, ss.65-67, 2022 (SCI-Expanded, Scopus, TRDizin)
  48. Assessing the genetic impact of Enterococcus faecalis infection on gastric cell line MKN74TÜRK S., Turk C., Temirci E. S., Malkan Ü. Y., UÇAR G., Ozguven S. V.ANNALS OF MICROBIOLOGY, cilt.71, sa.1, 2021 (SCI-Expanded, Scopus)
  49. Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia caseAfacan Ozturk H. B., Albayrak M., Maral S., Reis Aras M., Yilmaz F., Akyol P., et al.JOURNAL OF ONCOLOGY PHARMACY PRACTICE, cilt.27, sa.8, ss.2027-2029, 2021 (SCI-Expanded, Scopus)
  50. A CASE OF REFRACTORY IMMUNE THROMBOCYTOPENIA APPLIED WITH AUTOLOGOUS HEMATOPOETIC STEM CELL TRANSPLANTATIONKaradeniz M., Ucdal M. T., Goker H., Malkan Ü. Y.Hematology, Transfusion and Cell Therapy, cilt.43, ss.1-3, 2021 (ESCI, Scopus)
  51. Analysis of Demographic and Clinical Characteristics of Primary Myelofibrosis and Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis PatientsAkyol P., Yıldız A., Albayrak M., Öztürk H. B. A., Maral S., Aras M. R., et al.Gulhane Medical Journal, cilt.63, sa.2, ss.117-122, 2021 (Scopus, TRDizin)
  52. Assessment of ST2 and Reg3a levels in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantationALADAĞ KARAKULAK E., DEMİROĞLU H., Malkan Ü. Y., Akman U., GÖKER H., BÜYÜKAŞIK Y.TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.1, ss.355-358, 2021 (SCI-Expanded, Scopus, TRDizin)
  53. Interferon-Gene Family Alterations Following the SARS-Cov Infection in Association with Iron Metabolism and Lymphoid BiologyMalkan Ü. Y., TÜRK S., Turk C., Temirci E. S., Koker I., HAZNEDAROĞLU İ. C.UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, cilt.31, sa.2, ss.67-78, 2021 (SCI-Expanded, Scopus, TRDizin)
  54. A rare case of diffuse large B-cell lymphoma-associated hemophagocytic lymphohistiocytosisMALKAN Ü. Y., Albayrak M., Yildiz A., Maral S., Afacan Ozturk H. B., Comert P.JOURNAL OF ONCOLOGY PHARMACY PRACTICE, cilt.27, sa.1, ss.250-252, 2021 (SCI-Expanded, Scopus)
  55. The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients.Karataş A., Malkan Ü. Y., Velet M., Demiroğlu H., Büyükaşik Y., Telli Dizman G., et al.Turkish journal of medical sciences, cilt.51, ss.1647-1652, 2021 (SCI-Expanded, Scopus, TRDizin)
  56. Comparison of single and double autologous stem cell transplantation in multiple myeloma patientsMalkan Ü. Y., DEMİROĞLU H., BÜYÜKAŞIK Y., KARATAŞ A., ALADAĞ KARAKULAK E., GÖKER H.OPEN MEDICINE, cilt.16, sa.1, ss.192-197, 2021 (SCI-Expanded, Scopus)
  57. Current community transmission and future perspectives on the COVID-19 processTÜRK S., Turk C., Malkan Ü. Y., Temirci E. S., Peker M. C., HAZNEDAROĞLU İ. C.TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.3, ss.1001-1011, 2021 (SCI-Expanded, Scopus, TRDizin)
  58. Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposideTurk S., Turk C., Akbar M., Kucukkaraduman B., Isbilen M., Demirkol C., et al.PLOS ONE, cilt.15, sa.11, 2020 (SCI-Expanded, Scopus)
  59. In vitro analysis of the renin-angiotensin system and inflammatory gene transcripts in human bronchial epithelial cells after infection with severe acute respiratory syndrome coronavirusTurk C., TÜRK S., Temirci E. S., Malkan Ü. Y., HAZNEDAROĞLU İ. C.JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, cilt.21, sa.2, 2020 (SCI-Expanded, Scopus)
  60. Richter's transformation in patients with chronic lymphocytic leukemia: a cohort study about risk factorsOKAY M., GÜNEŞ G., Malkan Ü. Y., Heziyev T., GÖKER H., HAZNEDAROĞLU İ. C., et al.LEUKEMIA & LYMPHOMA, cilt.61, ss.50-52, 2020 (SCI-Expanded, Scopus)

All 117 on AVESİS →

Conference papers 97

  1. Clinical Validation of Innate Lymphoid Cell-Associated Gene Signatures in the TCGA Acute Myeloid Leukemia CohortTÜRK S., TOPRAK U., TÜRK C., MALKAN Ü. Y., HAZNEDAROĞLU İ. C.European Cooperation in Science and Technology (COST) COST Action CA24117 – “Innate Lymphoid Cells – the European Quest for Innovative Cancer Prognosis and Immunotherapy (ILCquest)” 1st Spring meeting, Belgrade, Sırbistan, 23 - 24 Mart 2026, (Özet Bildiri)
  2. Remodeling of the Innate Lymphoid Cell Compartment in Acute Myeloid Leukemia Revealed by an ILC-Centered Single-Cell Transcriptomic ReanalysisTÜRK C., TOPRAK U., TÜRK S., MALKAN Ü. Y., HAZNEDAROĞLU İ. C.European Cooperation in Science and Technology (COST) COST Action CA24117 – “Innate Lymphoid Cells – the European Quest for Innovative Cancer Prognosis and Immunotherapy (ILCquest)” 1st Spring meeting, Belgrade, Sırbistan, 23 - 24 Mart 2026, (Özet Bildiri)
  3. LENALIDOMID İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİBE KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIMDEMİROĞLU H., AKSU S., SAYINALP N., GÖKER H., BÜYÜKAŞIK Y., ÖZCEBE O. İ., et al.TÜRK HEMATOLOJİ DERNEĞİ, Türkiye, 31 Ekim - 03 Kasım 2018, (Tam Metin Bildiri)
  4. LENALİDOMİD İLE MYELOMDA OTOLOG NAKİL SONRASI İLK NÜKSDE TALİDOMİD VE BORTEZOMİB’E KIYASLA DAHA İYİ İLERLEMESİZ SAĞKALIMMALKAN Ü. Y., BÜYÜKAŞIK Y., DEMİROĞLU H., ÇİFTÇİLER R., GÜNEŞ G., OKAY M., et al.44.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Türkiye, 31 Ekim - 03 Kasım 2018, ss.191-192, (Özet Bildiri)
  5. Mitoxantrone-melphalan conditioning regimen for autologous stem cell transplantation in relapsed/refractory lymphomaOKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., CIFTCILER R., Aladag E., et al.9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri)
  6. Lenalidomide provide better progression free survival than thalidomide and bortezomib in the first relapse of multiple myeloma patients after autologous transplantationMalkan Ü. Y., Buyukasik Y., Demiroglu H., Ciftciler R., Gunes G., Okay M., et al.9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri)
  7. Descriptive analysis of myeloproliferative diseases and its complicationsOKAY M., MALKAN Ü. Y., BÖLEK E. Ç., Aladag E., HAZIYEV T., SAYINALP N., et al.9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 17 - 20 Ekim 2018, cilt.73, (Özet Bildiri)
  8. RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANNTRON-MELFALAN HAZIRLAMA REJİMİOKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., malkan Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.6. HEMATOLOJİK ONKOLOJİ KONGRESİ, Türkiye, 18 - 22 Eylül 2018, (Tam Metin Bildiri)
  9. RELAPS/REFRAKTER LENFOMADA OTOLOG KÖK HÜCRE TRANSPLANTASYONUNDA MİTOKSANTRON-MELFALAN HAZIRLAMA REJİMİOKAY M., BÜYÜKAŞIK Y., DEMİROĞLU H., MALKAN Ü. Y., ÇİFTÇİLER R., ALADAĞ KARAKULAK E., et al.5. HEMATOLOJİK ONKOLOJİ KONGRESİ, Kıbrıs (Kktc), 20 - 22 Eylül 2018, (Özet Bildiri)
  10. Amyloidosis Induced Abnormal coagulopathy associated with multible coagulation Factor Deficiencies.malkan Ü. Y., DEMİROĞLU H., AKSU S., HAZNEDAROĞLU İ. C., SAYINALP N.XXVI. Congress of the international society on Thrombosis and Haemostasis, Berlin, Almanya, 08 Temmuz 2017 - 13 Ocak 2018, cilt.1, ss.402, (Özet Bildiri)
  11. AN ANAPLASTIC THYROID CARCINOMA CASE PRESENTING WITH LEUCOERYTHROBLASTIC BLOOD PICTUREOkay M., Malkan Ü. Y., Can E. S., Gunes G., Demiroglu H.8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)
  12. COEXISTENCE OF REFRACTORY IMMUNE THROMBOCYTOPENIC PURPURA AND VITILIGO: A CASE REPORTCan E. S., Malkan Ü. Y., Albayrak M., Gunes G.8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)
  13. METHOTREXATE-RITUXIMAB TREATMENT IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A CASE REPORTCan E. S., Malkan Ü. Y., Albayrak M., Gunes G.8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)
  14. ELTROMBOPAG INDUCED HEPATOTOXICITY: A CASE REPORTCan E. S., Malkan Ü. Y., Albayrak M., Gunes G.8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)
  15. DIMETHYL SULFOXIDE-INDUCED TONIC-CLONIC SEIZURE DURING INFUSION OF AUTOLOGOUS STEM CELLMaral S., Albayrak M., Sahin O., Yildiz A., Pala C., Malkan Ü. Y., et al.8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)
  16. IMPORTANCE OF SCREENING ACCESSORY SPLEEN IN REFRACTORY IMMUNE THROMBOCYTOPENIASahin O., Albayrak M., Yildiz A., Maral S., Ozturk C. P., Ozturk H. A., et al.8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)
  17. AN UNMUTATED HYPEREOSINOPHILIC SYNDROME CASE THAT IS SUCCESFULLY TREATED WITH IMATINIB MESYLATECan E. S., Malkan Ü. Y., Albayrak M., Gunes G.8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)
  18. SJOGREN SYNDROME RELATED IMMUNE THROMBOCYTOPENIC PURPURA: A CASE REPORTCan E. S., Malkan Ü. Y., Albayrak M., Gunes G.8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)
  19. A CASE OF LARGE GRANULAR LYMPHOCYTIC LEUKEMIA WITH AN UNUSUAL IMMUNOPHENOTYPEOkay M., Malkan Ü. Y., Can E. S., Gunes G., Demiroglu H.8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)
  20. BLEOMYCIN-INDUCED PULMONARY FIBROSIS: EXPERIENCE OF TWO CASES IN A SINGLE CENTREMaral S., Albayrak M., Yildiz A., Sahin O., Ozturk C., Malkan Ü. Y., et al.8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)
  21. THE CORRELATION BETWEEN THE JAK2 ALLELE BURDEN AND HEMATOLOGIC/ CLINICAL PARAMETERS OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASIA PATIENTSCan E. S., Malkan Ü. Y., Okay M., Albayrak M., Gunes G.8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)
  22. THE EFFECT OF DISEASE STATUS BEFORE HEMATOPOIETIC STEM CELL TRANSPLANTATION ON OVERALL SURVIVAL IN MULTIPLE MYELOMAGunes G., Malkan Ü. Y., Can E. S., Yayar O., Okay M., Goker H.8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)
  23. SYNCHRONOUS GRANULOCYTIC SARCOMA AND MYCOBACTERIUM TUBERCULOSIS DIAGNOSED IN AN AXILLARY LYMPH NODEMalkan Ü. Y., Khurami F. A., Arslankoz S., Arikok A., Can E. S., Albayrak M., et al.8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)
  24. A CASE REPORT: IMATINIB-RELATED PSORIASIFORM DERMATITISSahin O., Albayrak M., Yildiz A., Maral S., Gunes G., Ozturk C. P., et al.8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)
  25. COMPARISON OF BORTEZOMIB AND LENALIDOMIDE BASED REGIMENS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA PATIENTSMalkan Ü. Y., Gunes G., Yayar O., Can E. S., Okay M., Goker H.8th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Türkiye, 18 - 21 Ekim 2017, cilt.61, (Özet Bildiri)
  26. Kemoterapiye refrakter primer mediastinal granülositik sarkom hastasının allojeneik kök hücre transplantasyonu ile tedavisiETGÜL S., MALKAN Ü. Y., TURGUT M., DEMİROĞLU H., BÜYÜKAŞIK Y., HAZNEDAROĞLU İ. C., et al.2. Hematolojik Onkoloji Kongresi, Kıbrıs (Kktc), 16 - 19 Şubat 2017, (Özet Bildiri)
  27. Experience with Pegylated Interferon alpha-2a in 30 Patients Diagnosed with Hematologic NeoplasmsBahcecioglu A. B., Etgul S., Aslan T., Aydin M. S., Malkan Ü. Y., Okay M., et al.58th Annual Meeting and Exposition of the American-Society-of-Hematology, California, Amerika Birleşik Devletleri, 3 - 06 Aralık 2016, cilt.128, (Özet Bildiri)
  28. A HYPERHEMOLYTIC SYNDROME CASEOkay M., Ciftciler R., Malkan Ü. Y., Gunes G., Buyukasik Y.7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)
  29. ERDHEIM-CHESTER DISEASE: A CASE REPORTCiftciler R., Okay M., Malkan Ü. Y., Gunes G., Buyukasik Y.7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)
  30. A CATASTROPHIC SERONEGATIVE ANTIPHOSPHOLIPID SYNDROME CASEMalkan Ü. Y., Gunes G., Okay M., Ciftciler R., Buyukasik Y.7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)
  31. DERMATOSIS CAUSED BY ENOXAPARIN TREATMENT: A CASE REPORTOkay M., Ciftciler R., Malkan Ü. Y., Gunes G., Buyukasik Y.7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)
  32. A MYELOFIBROSIS CASE THAT DEVELOPS MYCOBACTERIUM INFECTION AFTER RUXOLITINIB TREATMENTMalkan Ü. Y., Gunes G., Okay M., Haznedaroglu I.7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)
  33. AN OSLER WEBER RENDU SYNDROME CASE THAT WAS SUCCESSFULLY TREATED WITH BEVACIZUMABMalkan Ü. Y., Gunes G., Okay M., Aksu S., Buyukasik Y.7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)
  34. ATYPICAL CLINICAL PRESENTATION OF A HODGKIN LYMPHOMA CASEOkay M., Ciftciler R., Malkan Ü. Y., Gunes G., Saglam A., Buyukasik Y.7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)
  35. GASTRIC INVOLVEMENT AS CLINICAL PRESENTATION OF BURKITT LYMPHOMA: A CASE REPORTMalkan Ü. Y., Gunes G., Okay M., Haznedaroglu I.7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)
  36. COEXISTENCE OF LARGE GRANULAR LYMPHOCYTIC LEUKEMIA AND AUTOIMMUNE HEMOLYTIC ANEMIA: A CASE REPORTMalkan Ü. Y., Gunes G., Okay M., Ciftciler R., Aksu S.7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)
  37. IBRUTINIB TREATMENT IN RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA: A CASE REPORTMalkan Ü. Y., Gunes G., Okay M., Aksu S., Sayinalp N.7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)
  38. THE COEXISTENCE OF ANGIOIMMUNOBLASTIC T CELL LYMPHOMA, CHRONIC MYELOMONOCYTIC LEUKEMIA AND EBV: A CASE REPORTMalkan Ü. Y., Gunes G., Okay M., Demiroglu H.7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)
  39. THE COEXISTENCE OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CASTLEMAN SYNDROME: A CASE REPORTMalkan Ü. Y., Gunes G., Okay M., Haznedaroglu I., Ozcebe O.7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)
  40. ANCA POSITIVE VASCULITIS THAT WAS TRIGGERED AFTER BENDAMUSTINE-RITUXIMAB TREATMENT: A CASE REPORTMalkan Ü. Y., Gunes G., Okay M., Haznedaroglu I., Sayinalp N.7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)
  41. AN IGE MYELOMA CASEOkay M., Ciftciler R., Malkan Ü. Y., Gunes G., Buyukasik Y.7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)
  42. AN INV(16) POSITIVE ACUTE MYELOMONOCYTIC LEUKEMIA CASE WITH POOR PROGNOSISMalkan Ü. Y., Gunes G., Okay M., Ciftciler R., Aksu S.7th International Eurasian Hematology Congress, İstanbul, Türkiye, 13 - 16 Ekim 2016, cilt.49, (Özet Bildiri)
  43. Determination of chemoterapoetic drugsensitivity subgroups of acute leukemiaTürk S., Ghasemi M., malkan Ü. Y., ERİKÇİ A., GÖKER H., HAZNEDAROĞLU İ. C., et al.The FEBS Journal, 3 - 08 Eylül 2016, (Özet Bildiri)
  44. Determination of chemoterapoetic drug sensitivity subgroups of acute leukemiaTÜRK S., Ghasemi M., MALKAN Ü. Y., Erikci A., GÖKER H., SAYINALP N., et al.41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.373-374, (Özet Bildiri)
  45. USE OF ELTROMBOPAG IN IMMUNE THROMBOCYTOPENIA IN TURKEYCekdemir D., Ozdemirkiran F., Guvenc S., Eser A., Ozkocaman V., Sahin H. H., et al.24th Biennial International Congress on Thrombosis / EMLTD Congress, İstanbul, Türkiye, 4 - 07 Mayıs 2016, cilt.141, (Özet Bildiri)
  46. A CASE OF GRANULOCYTIC SARCOMA PRESENTING WITH CENTRAL NERVOUS SYSTEM INVOLVEMENTGunes G., Malkan Ü. Y., Eliacik E., Yayar O., Aksu S., Haznedaroglu I.6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
  47. A CASE OF CASTLEMAN DISEASE MANIFESTED WITH A MASS ASSOCIATED WITH THE RIGHT ATRIUMGunes G., Malkan Ü. Y., Aksu S., Demiroglu H., Ozcebe O.6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
  48. TREATMENT OF PYODERMA GANGRENOSUM WITH THALIDOMIDE IN MYELODYSPLASTIC SYNDROME: A CASE REPORTMalkan Ü. Y., GÜNEŞ G., Yayar O., Aslan T., AKSU S., HAZNEDAROĞLU İ. C.6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
  49. AN IGD MYELOMA CASE THAT IS RESISTANT TO CARFILZOMIBMalkan Ü. Y., GÜNEŞ G., ETGÜL S., HAZNEDAROĞLU İ. C., DEMİROĞLU H., GÖKER H.6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
  50. MIXED PHENOTYPE ACUTE LEUKEMIA PRESENTING WITH EXTREME THROMBOCYTOSISGunes G., Malkan Ü. Y., Etgul S., Yayar O., Demiroglu H., Buyukasik Y.6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
  51. STERNAL INVOLVEMENT OF MULTIPLE MYELOMA AS AN INITIAL LESION: AN UNUSUAL LOCALIZATIONGunes G., Malkan Ü. Y., Yayar O., Aslan T., Goker H., Aksu S.6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
  52. A WALDENSTROM MACROGLOBINEMIA CASE WITH CRANIAL INVOLVEMENTMalkan Ü. Y., Gunes G., Etgul S., Sayinalp N., Aksu S., Haznedaroglu I. C.6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
  53. CLINICOPATHOLOGICAL ASSOCIATIONS OF ACQUIRED ERYTHROBLASTOPENIAGunes G., Malkan Ü. Y., Eliacik E., Yayar O., Etgul S., Aslan T., et al.6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
  54. COMMON VARIABLE IMMUNE DEFICIENCY-ASSOCIATED HODGKIN'S LYMPHOMA COMPLICATED WITH EBV-LINKED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: A CASE REPORTMalkan Ü. Y., Gunes G., Etgul S., Aksu S., Haznedaroglu I. C., Buyukasik Y.6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
  55. CAUSES AND SIGNIFICANCE OF HEMOPHAGOCYTOSIS IN BONE MARROW ASPIRATION IN A TERTIARY-CARE MEDICAL CENTEREtgul S., Aslan T., Malkan Ü. Y., Gunes G., Aydin S., Ozmen F., et al.6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
  56. BLEOMYCIN-INDUCED INTERSTITIAL LUNG DISEASE: A CASE REPORTMalkan Ü. Y., GÜNEŞ G., Aslan T., AKSU S., HAZNEDAROĞLU İ. C., BÜYÜKAŞIK Y.6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
  57. A T-CELL PROLYMPHOCYTIC LEUKEMIA CASE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENTMalkan Ü. Y., Gunes G., Eliacik E., Yayar O., Goker H., Demiroglu H.6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
  58. A COMPOSITE LYMPHOMA CASEMalkan Ü. Y., GÜNEŞ G., Yayar O., DEMİROĞLU H., GÖKER H., HAZNEDAROĞLU İ. C.6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
  59. A LATE-ONSET ACUTE GRAFT VERSUS HOST DISEASE CASE WHO IS RESISTANT TO BOTH TACROLIMUS AND CYCLOSPORINEMalkan Ü. Y., GÜNEŞ G., Aslan T., AKSU S., GÖKER H., HAZNEDAROĞLU İ. C.6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)
  60. SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS DUE TO AUTOIMMUNE, HEMATOLOGIC, INFECTIOUS DISEASES IN ADULT PATIENTSEtgul S., Aslan T., Gunes G., Malkan Ü. Y., AYDIN DİLSİZ S., Ozmen F., et al.6th International Eurasian Hematology Congress, Antalya, Türkiye, 14 - 18 Ekim 2015, cilt.39, (Özet Bildiri)

All 97 on AVESİS →

Контакты

Отделение
Гематология, Больница для взрослых
Владение языками
English

Последнее обновление: